CN102614462B - 治疗冠心病的中药组合物及其制备方法 - Google Patents
治疗冠心病的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN102614462B CN102614462B CN 201210091229 CN201210091229A CN102614462B CN 102614462 B CN102614462 B CN 102614462B CN 201210091229 CN201210091229 CN 201210091229 CN 201210091229 A CN201210091229 A CN 201210091229A CN 102614462 B CN102614462 B CN 102614462B
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- preparation
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 83
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims description 42
- 108010052008 colla corii asini Proteins 0.000 claims abstract description 20
- 229940079593 drug Drugs 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 239000000843 powder Substances 0.000 claims description 26
- 239000009636 Huang Qi Substances 0.000 claims description 19
- 241000217407 Margaritifera Species 0.000 claims description 18
- 239000009286 sanguis draxonis Substances 0.000 claims description 17
- 230000000149 penetrating effect Effects 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 4
- 241000972155 Moschus Species 0.000 claims 4
- 230000000694 effects Effects 0.000 abstract description 32
- 230000006870 function Effects 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 2
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 abstract 1
- 240000005979 Hordeum vulgare Species 0.000 abstract 1
- 235000007340 Hordeum vulgare Nutrition 0.000 abstract 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 24
- 239000008280 blood Substances 0.000 description 24
- 208000002193 Pain Diseases 0.000 description 19
- 244000153234 Hibiscus abelmoschus Species 0.000 description 15
- 230000001737 promoting effect Effects 0.000 description 15
- 210000004072 lung Anatomy 0.000 description 13
- 206010002383 Angina Pectoris Diseases 0.000 description 12
- 239000000796 flavoring agent Substances 0.000 description 12
- 235000019634 flavors Nutrition 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 12
- 206010011224 Cough Diseases 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 10
- 210000000038 chest Anatomy 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 206010008479 Chest Pain Diseases 0.000 description 9
- 239000002775 capsule Substances 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 206010061876 Obstruction Diseases 0.000 description 8
- 230000003203 everyday effect Effects 0.000 description 8
- 239000003826 tablet Substances 0.000 description 8
- 230000036770 blood supply Effects 0.000 description 7
- 210000004351 coronary vessel Anatomy 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 206010047700 Vomiting Diseases 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 206010025482 malaise Diseases 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000002552 dosage form Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 208000010125 myocardial infarction Diseases 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 208000019790 abdominal distention Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 231100000862 numbness Toxicity 0.000 description 4
- 208000037920 primary disease Diseases 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 210000000115 thoracic cavity Anatomy 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 206010000891 acute myocardial infarction Diseases 0.000 description 3
- 229940127219 anticoagulant drug Drugs 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 208000031225 myocardial ischemia Diseases 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010008469 Chest discomfort Diseases 0.000 description 2
- 241000756943 Codonopsis Species 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000218176 Corydalis Species 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241000222336 Ganoderma Species 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 2
- 239000000006 Nitroglycerin Substances 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000032023 Signs and Symptoms Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 229960003711 glyceryl trinitrate Drugs 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 239000009912 gualou xiebai baijiutang Substances 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 241000242759 Actiniaria Species 0.000 description 1
- 241000271039 Agkistrodon Species 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000255791 Bombyx Species 0.000 description 1
- 206010007513 Cardiac aneurysm Diseases 0.000 description 1
- 206010007556 Cardiac failure acute Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010052895 Coronary artery insufficiency Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 241000237903 Hirudo Species 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 241000283956 Manis Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000237636 Pheretima Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 1
- 241000131808 Scolopendra Species 0.000 description 1
- 241000522620 Scorpio Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000000489 anti-atherogenic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- -1 electuary Substances 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 1
- 229960002237 metoprolol Drugs 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 208000023482 precordial pain Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000009490 scorpio Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210091229 CN102614462B (zh) | 2012-03-31 | 2012-03-31 | 治疗冠心病的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210091229 CN102614462B (zh) | 2012-03-31 | 2012-03-31 | 治疗冠心病的中药组合物及其制备方法 |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310235393.XA Division CN103285328B (zh) | 2012-03-31 | 2012-03-31 | 治疗冠心病的中药组合物胶囊的制备方法 |
CN201310235381.7A Division CN103330911B (zh) | 2012-03-31 | 2012-03-31 | 治疗冠心病的中药组合物粉剂及其制备方法 |
CN201310235384.0A Division CN103285327B (zh) | 2012-03-31 | 2012-03-31 | 治疗冠心病的中药组合物片剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102614462A CN102614462A (zh) | 2012-08-01 |
CN102614462B true CN102614462B (zh) | 2013-08-14 |
Family
ID=46554910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210091229 Active CN102614462B (zh) | 2012-03-31 | 2012-03-31 | 治疗冠心病的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102614462B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104800644A (zh) * | 2014-01-17 | 2015-07-29 | 李庆方 | 治疗肺结核的中药组合物及其制备方法 |
CN104189668A (zh) * | 2014-08-01 | 2014-12-10 | 济南环太机电技术有限公司 | 一种治疗冠心病的中药组合物 |
CN108543035A (zh) * | 2018-06-27 | 2018-09-18 | 周舜宁 | 一种治疗冠心病的中药组合物 |
-
2012
- 2012-03-31 CN CN 201210091229 patent/CN102614462B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102614462A (zh) | 2012-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102648946A (zh) | 熥敷热疗液及其制备方法 | |
CN104740289A (zh) | 一种治疗冠心病的中药 | |
CN102058870B (zh) | 一种治疗风湿类风湿关节痛中风偏瘫的药物及其制备方法 | |
CN102755626B (zh) | 一种治疗病态窦房结综合症的中药组合物及制备方法 | |
CN104173773A (zh) | 偏头痛祛风活血制剂及制备方法 | |
CN103893670B (zh) | 一种治疗心脑血管病的中药药丸 | |
CN102614462B (zh) | 治疗冠心病的中药组合物及其制备方法 | |
CN102614460B (zh) | 治疗心肌梗塞的中药组合物及其制备方法 | |
CN103285328B (zh) | 治疗冠心病的中药组合物胶囊的制备方法 | |
CN103285327B (zh) | 治疗冠心病的中药组合物片剂及其制备方法 | |
CN103330911B (zh) | 治疗冠心病的中药组合物粉剂及其制备方法 | |
CN105727001A (zh) | 一种治疗心脑血管疾病的中药组合物 | |
CN101530556B (zh) | 治疗心绞痛的中药制剂 | |
CN104800610A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
CN104547553A (zh) | 一种治疗神经性内分泌紊乱的中药 | |
CN104117020A (zh) | 一种治疗心房颤动的中药配方 | |
CN103860990B (zh) | 冠心病活血通络散剂及制备方法 | |
CN102961540A (zh) | 一种治疗冠心病的药物及其制备方法 | |
CN102614459B (zh) | 快速治疗心肌缺血的中药喷雾剂及其制备方法 | |
CN102614461A (zh) | 快速缓解心绞痛的喷雾剂及其制备方法 | |
CN103142942B (zh) | 治疗心肌梗塞的中药组合物片剂及其制备方法 | |
CN103142941B (zh) | 治疗心肌梗塞的中药组合物胶囊及其制备方法 | |
CN105748911A (zh) | 术后肿瘤患者抗副反应胶囊剂的制备方法 | |
CN103285335A (zh) | 治疗气血两亏的中药制剂 | |
CN103157068B (zh) | 治疗心肌梗塞的中药组合物粉剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGDONG HUABO ENTERPRISE MANAGEMENT CONSULTING C Free format text: FORMER OWNER: LI HAOCHENG Effective date: 20140521 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250014 JINAN, SHANDONG PROVINCE TO: 510640 GUANGZHOU, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140521 Address after: 510640 Guangdong city of Guangzhou province Tianhe District gold Yinglu No. 1 was 1106 room two Patentee after: Guangdong Huabo Enterprise Management Consulting Co., Ltd. Address before: 250014 Shandong Institute of politics and law, No. 63 Jiefang East Road, Lixia District, Shandong, Ji'nan Patentee before: Li Haocheng |
|
ASS | Succession or assignment of patent right |
Owner name: QIDONG HUILONG WANXIANG FLOWER NURSERY Free format text: FORMER OWNER: GUANGDONG HUABO ENTERPRISE MANAGEMENT CONSULTING CO., LTD. Effective date: 20140715 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 510640 GUANGZHOU, GUANGDONG PROVINCE TO: 226299 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140715 Address after: Qidong huilongzhen 54 226299 villages in Jiangsu province Nantong City Service Center (south side) Patentee after: Qidong Huilong Vientiane Garden Address before: 510640 Guangdong city of Guangzhou province Tianhe District gold Yinglu No. 1 was 1106 room two Patentee before: Guangdong Huabo Enterprise Management Consulting Co., Ltd. |